Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hang-xing Bao, Qing Bi, Yong Han, Chen Zhao & Hai Zou. (2017) Potential mechanisms underlying CDK5 related Osteosarcoma progression. Expert Opinion on Therapeutic Targets 21:5, pages 455-460.
Read now
Read now
Articles from other publishers (20)
Hailong Tian, Jiangjun Cao, Bowen Li, Edouard C. Nice, Haijiao Mao, Yi Zhang & Canhua Huang. (2023) Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Research 11:1.
Crossref
Crossref
Natalia Todosenko, Kristina Yurova, Olga Khaziakhmatova, Vladimir Malashchenko, Igor Khlusov & Larisa Litvinova. (2022) Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells. Pharmaceutics 14:10, pages 2181.
Crossref
Crossref
Yubao Lu, Jiahe Zhang, Yutong Chen, Yuchen Kang, Zhipeng Liao, Yuanqi He & Cangyu Zhang. (2022) Novel Immunotherapies for Osteosarcoma. Frontiers in Oncology 12.
Crossref
Crossref
Zhiyuan Guan, Shengfu Liu, Liying Luo, Zhong Wu, Shan Lu, Zhiqiang Guan & Kun Tao. (2022) Identification of Ferroptosis-Related Genes as Biomarkers for Sarcoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
N. E. Kushlinskii, O. V. Kovaleva, A. A. Alferov, Yu. B. Kuzmin, E. A. Sushentsov & I. S. Stilidi. (2021) Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms. Almanac of Clinical Medicine 49:3, pages 179-190.
Crossref
Crossref
Bingsheng Yang, Zexin Su, Guoli Chen, Zhirui Zeng, Jianye Tan, Guofeng Wu, Shuang Zhu & Lijun Lin. (2021) Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma. Oncology Letters 21:3.
Crossref
Crossref
Maroun Bou Zerdan, Aram H Bidikian, Ibrahim Alameh, Clara El Nakib & Hazem I Assi. (2021) Olaratumab’s failure in soft tissue sarcoma. Rare Tumors 13, pages 203636132110341.
Crossref
Crossref
Jiaming He, Wenkan Zhang, Tuoyu Di, Jiahong Meng, Yiying Qi, Guoqi Li, Yuxiang Zhang, Hang Su & Weiqi Yan. (2020) Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody. Biomedicine & Pharmacotherapy 131, pages 110541.
Crossref
Crossref
N. E. Kushlinskii, A. A. Alferov, Yu. S. Timofeev, E. S. Gershtein, I. V. Bulycheva, A. V. Bondarev, M. Yu. Shchupak, N. Yu. Sokolov, S. B. Polikarpova, M. M. Efimova, A. A. Dzampaev, E. A. Sushentsov, M. D. Aliev & E. R. Musaev. (2020) Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors. Bulletin of Experimental Biology and Medicine 170:1, pages 64-68.
Crossref
Crossref
Hiroki Tadano, Tomohide Tsukahara, Emi Mizushima, Asuka Akamatsu, Kazue Watanabe, Iyori Nojima, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Noriyuki Sato & Toshihiko Torigoe. (2020) Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8. British Journal of Cancer 123:9, pages 1387-1394.
Crossref
Crossref
M. Akhtar Anwar, Chirine El-Baba, Muhammed H. Elnaggar, Yasmeen O. Elkholy, Mohamed Mottawea, Dina Johar, Tuqa S. Al Shehabi, Firas Kobeissy, Charbel Moussalem, Elie Massaad, Ibrahim Omeis, Nadine Darwiche & A.H. Eid. (2020) Novel therapeutic strategies for spinal osteosarcomas. Seminars in Cancer Biology 64, pages 83-92.
Crossref
Crossref
Tomohide Tsukahara, Kazue Watanabe, Kenji Murata, Akari Takahashi, Emi Mizushima, Yuji Shibayama, Hidekazu Kameshima, Ryo Hatae, Yasuo Ohno, Rituko Kawahara, Aiko Murai, Munehide Nakatsugawa, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Takeshi Terui, Hiroko Asanuma, Tadashi Hasegawa, Noriyuki Sato & Toshihiko Torigoe. (2019) Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma. Cancer Immunology, Immunotherapy 69:2, pages 189-197.
Crossref
Crossref
Kazue Watanabe, Tomohide Tsukahara, Shingo Toji, Shogo Saitoh, Yoshihiko Hirohashi, Munehide Nakatsugawa, Terufumi Kubo, Takayuki Kanaseki, Hidekazu Kameshima, Takeshi Terui, Noriyuki Sato & Toshihiko Torigoe. (2019) Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells. Cancer Science 110:1, pages 40-51.
Crossref
Crossref
Daokui Qu, Hongbing Wang, Qiuling Bi, Jiangli Xiu, Zhen Liu & Chunsheng Wang. (2018) (S)-(-)-N-[2-(3-Hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide enhanced the efficacy of anti-PD1 against osteosarcoma cancer. Journal of Bone Oncology.
Crossref
Crossref
Vivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, Brian A. Menegaz, Pamela Camacho, Winston Huh, Vandhana Ramamoorthy, Pete M. Anderson, Raphael E. Pollock, Dina C. Lev, Wei Qiao, Mary Frances McAleer, Robert S. Benjamin, Shreyaskumar Patel, Cynthia E. Herzog, Najat C. Daw, Barry W. Feig, Alexander J. Lazar, Andrea Hayes-Jordan & Joseph A. Ludwig. (2018) Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clinical Cancer Research 24:19, pages 4865-4873.
Crossref
Crossref
Liming Xia, Hao Wu & Wenkang Qian. (2018) Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma. Journal of Bone Oncology 12, pages 61-64.
Crossref
Crossref
HongYue Lin, YuZhu Wu, JinPing Chen, ShuRong Huang & YangQiang Wang. (2018) (−)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) Quinic Acid Inhibits the Function of Myeloid-Derived Suppressor Cells to Enhance the Efficacy of Anti-PD1 against Colon Cancer. Pharmaceutical Research 35:9.
Crossref
Crossref
Yuji Shibayama, Tomohide Tsukahara, Makoto Emori, Kenji Murata, Emi Mizushima, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Toshihiko Yamashita, Noriyuki Sato & Toshihiko Torigoe. (2017) Implication of chemo‐resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy. Cancer Science 108:9, pages 1739-1745.
Crossref
Crossref
Tomohide Tsukahara, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Noriyuki Sato & Toshihiko Torigoe. (2016) Peptide vaccination therapy: Towards the next generation. Pathology International 66:10, pages 547-553.
Crossref
Crossref
Zhan Wang, Binghao Li, Yingqing Ren & Zhaoming Ye. (2016) T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities. Frontiers in Immunology 7.
Crossref
Crossref